Industry Voice: BMO's latest engagement - a focus on social issues
Historically difficult for investors to define and quantify, social issues are now among the most pressing issues for companies globally – discover our engagement on some of these issues, including antimicrobial resistance in Q4 2020.
Raising awareness on antimicrobial resistance (AMR)
Engagement progress update
Antimicrobial Resistance (AMR) is a natural phenomenon in which microorganisms develop resistance to antimicrobial agents. However, it is being accelerated by poor stewardship of antibiotics in healthcare and farming: antimicrobial-resistant microbes can spread between people and animals, and from person to person. As a result, a growing number of common bacterial infections - from pneumonia to urinary tract infections - are becoming more difficult to treat. If antibiotics continue to lose their effectiveness, caesarean sections and chemotherapy, as well as other commonplace medical interventions, could become extremely high risk and severely undermine modern medicine.
Disclaimers:
The value of investments and any income derived from them can go down as well as up as a result of market or currency movements and investors may not get back the original amount invested. Views and opinions have been arrived at by BMO Global Asset Management and should not be considered to be a recommendation or solicitation to buy or sell any stocks or products that may be mentioned.
© 2021 BMO Global Asset Management. Financial promotions are issued for marketing and information purposes; in the United Kingdom by BMO Asset Management Limited, which is authorised and regulated by the Financial Conduct Authority.
